200,000+ products from a single source!
sales@angenechem.com
6628-04-2 | 2-Methylquinolin-4-amine
CAS No: 6628-04-2 Catalog No: AG003KOQ MDL No:MFCD00006759
Product Description
Catalog Number:
AG003KOQ
Chemical Name:
2-Methylquinolin-4-amine
CAS Number:
6628-04-2
Molecular Formula:
C10H10N2
Molecular Weight:
158.1998
MDL Number:
MFCD00006759
IUPAC Name:
2-methylquinolin-4-amine
InChI:
InChI=1S/C10H10N2/c1-7-6-9(11)8-4-2-3-5-10(8)12-7/h2-6H,1H3,(H2,11,12)
InChI Key:
COCFIBRMFPWUDW-UHFFFAOYSA-N
SMILES:
Cc1cc(N)c2c(n1)cccc2
EC Number:
229-604-4
UNII:
5YZ7028HHH
NSC Number:
60281
Properties
Complexity:
158
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
158.084g/mol
Formal Charge:
0
Heavy Atom Count:
12
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
158.204g/mol
Monoisotopic Mass:
158.084g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2
Literature
| Title | Journal |
|---|---|
| Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents. | Medicinal chemistry (Shariqah (United Arab Emirates)) 20121101 |
| Cellular mechanisms of desynchronizing effects of hypothermia in an in vitro epilepsy model. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20120101 |
| Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase. | Journal of medicinal chemistry 20110113 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R). | Bioorganic & medicinal chemistry 20100815 |
| Ab initio, density functional theory and structural studies of 4-amino-2-methylquinoline. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091001 |
| Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence. | Bioorganic & medicinal chemistry 20090815 |
| 4-Amino-2-methyl-quinoline monohydrate. | Acta crystallographica. Section E, Structure reports online 20080601 |
| 4-Amino-2-methyl-quinolinium hydrogensulfate dihydrate. | Acta crystallographica. Section E, Structure reports online 20080101 |
| Glomerulus-specific, long-latency activity in the olfactory bulb granule cell network. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20061108 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Dequalinium-induced protofibril formation of alpha-synuclein. | The Journal of biological chemistry 20060210 |
| Parallel synthesis of diarylureas and their evaluation as inhibitors of insulin-like growth factor receptor. | Journal of combinatorial chemistry 20060101 |
| LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II. | Purinergic signalling 20051201 |
| Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog. | British journal of pharmacology 20050801 |
| A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists. | European journal of medicinal chemistry 20041201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.